based drug company focused on pain management therapies, has completed a $25 million private placement of common stock. Venture capital firm SV Life Sciences led the deal. NeurogesX went public last May, after having raised around $90 ...
- Recent posts
- NeurogesX Lights PIPE
- Georgia Cancer Specialists to Sponsor Sixth Annual 'Totes 2 Tots ...
- Pain Relief for Some, With an Odd Tradeoff
- When Coming Out Makes or Breaks a Family
- Issue of Drugs and Pain Strikes a Nerve
- Cervical Cancer Shots Are Gaining Reputation as Painful
- Study: minorities are less likely to receive narcotics for pain in ...
- Rite Aid and Lindora Offer Free Weight Management Program and ...
- Alternative Medical Techniques
- Minorities less likely to get pain relief in U.S.
- APPG on Fibromyalgia & Symposium on Neuropathic Pain
- Very personal study earns WSU professor an award
- Use of the ON-Q pain pump management system in the head and neck ...
- Comment on Open Thread….. by Jill in StL
- Comparison of psychological and physical function in neuropathic ...
- Aiken Neurosciences introduces new center for pain treatments
- PROFNET EXPERT ALERTS: Government, Health & Living
- Somatic Systems Announces Additional Coverage for Television Show ...
- Sex your way to fitness
- FDA Warns of Deaths From Fentanyl Patch